A gene expression signature identifies two prognostic subgroups of basal breast cancer (original) (raw)
Bertucci F, Finetti P, Cervera N et al (2006) Gene expression profiling and clinical outcome in breast cancer. Omics 10:429–443 ArticlePubMedCAS Google Scholar
Sorlie T, Perou CM, Tibshirani R et al (2001) Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci USA 98:10869–10874 ArticlePubMedCAS Google Scholar
Sorlie T, Tibshirani R, Parker J et al (2003) Repeated observation of breast tumor subtypes in independent gene expression data sets. Proc Natl Acad Sci USA 100:8418–8423 ArticlePubMedCAS Google Scholar
Sorlie T, Wang Y, Xiao C et al (2006) Distinct molecular mechanisms underlying clinically relevant subtypes of breast cancer: gene expression analyses across three different platforms. BMC Genomics 7:127 ArticlePubMed Google Scholar
Carey LA, Perou CM, Livasy CA et al (2006) Race, breast cancer subtypes, and survival in the Carolina breast cancer study. JAMA 295:2492–2502 ArticlePubMedCAS Google Scholar
Adelaide J, Finetti P, Bekhouche I et al (2007) Integrated profiling of basal and luminal breast cancers. Cancer Res 67:11565–11575 ArticlePubMedCAS Google Scholar
Bertucci F, Finetti P, Cervera N et al (2009) How different are luminal A and basal breast cancers? Int J Cancer 124:1338–1348 ArticlePubMedCAS Google Scholar
Pusztai LI (2009) Gene expression profiling of breast cancer. Breast Cancer Res 11 Suppl 3:S11 ArticlePubMed Google Scholar
Troester MA, Hoadley KA, Sorlie T et al (2004) Cell-type-specific responses to chemotherapeutics in breast cancer. Cancer Res 64:4218–4226 ArticlePubMedCAS Google Scholar
Desmedt C, Haibe-Kains B, Wirapati P et al (2008) Biological processes associated with breast cancer clinical outcome depend on the molecular subtypes. Clin Cancer Res 14:5158–5165 ArticlePubMedCAS Google Scholar
van de Vijver MJ, He YD, van’t Veer LJ et al (2002) A gene-expression signature as a predictor of survival in breast cancer. N Engl J Med 347:1999–2009 ArticlePubMed Google Scholar
van ‘t Veer LJ, Dai H, van de Vijver MJ et al (2002) Gene expression profiling predicts clinical outcome of breast cancer. Nature 415:530–536 ArticlePubMed Google Scholar
Sotiriou C, Wirapati P, Loi S et al (2006) Gene expression profiling in breast cancer: understanding the molecular basis of histologic grade to improve prognosis. J Natl Cancer Inst 98:262–272 ArticlePubMedCAS Google Scholar
Chang HY, Sneddon JB, Alizadeh AA et al (2004) Gene expression signature of fibroblast serum response predicts human cancer progression: similarities between tumors and wounds. PLoS Biol 2:E7 ArticlePubMed Google Scholar
Paik S, Shak S, Tang G et al (2004) A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. N Engl J Med 351:2817–2826 ArticlePubMedCAS Google Scholar
Miller LD, Smeds J, George J et al (2005) An expression signature for p53 status in human breast cancer predicts mutation status, transcriptional effects, and patient survival. Proc Natl Acad Sci USA 102:13550–13555 ArticlePubMedCAS Google Scholar
Wang Y, Klijn JG, Zhang Y et al (2005) Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer. Lancet 365:671–679 PubMedCAS Google Scholar
Liu R, Wang X, Chen GY et al (2007) The prognostic role of a gene signature from tumorigenic breast-cancer cells. N Engl J Med 356:217–226 ArticlePubMedCAS Google Scholar
Rody A, Holtrich U, Pusztai L et al (2009) T-cell metagene predicts a favorable prognosis in estrogen receptor-negative and HER2-positive breast cancers. Breast Cancer Res 11:R15 ArticlePubMed Google Scholar
Teschendorff AE, Caldas CI (2008) A robust classifier of high predictive value to identify good prognosis patients in ER-negative breast cancer. Breast Cancer Res 10:R73 ArticlePubMed Google Scholar
Teschendorff AE, Miremadi A, Pinder SE, Ellis IO, Caldas CI (2007) An immune response gene expression module identifies a good prognosis subtype in estrogen receptor negative breast cancer. Genome Biol 8:R157 ArticlePubMed Google Scholar
Kreike B, van Kouwenhove M, Horlings H et al (2007) Gene expression profiling and histopathological characterization of triple-negative/basal-like breast carcinomas. Breast Cancer Res 9:R65 ArticlePubMed Google Scholar
Da Silva L, Clarke C, Lakhani SRI (2007) Demystifying basal-like breast carcinomas. J Clin Pathol 60:1328–1332 ArticlePubMedCAS Google Scholar
Olivotto IA, Bajdik CD, Ravdin PM et al (2005) Population-based validation of the prognostic model ADJUVANT! for early breast cancer. J Clin Oncol 23:2716–2725 ArticlePubMed Google Scholar
Dent R, Hanna WM, Trudeau M et al (2009) Time to disease recurrence in basal-type breast cancers: effects of tumor size and lymph node status. Cancer 115:4917–4923 Google Scholar
Schneider BP, Winer EP, Foulkes WD et al (2008) Triple-negative breast cancer: risk factors to potential targets. Clin Cancer Res 14:8010–8018 ArticlePubMedCAS Google Scholar
Palmieri D, Lockman PR, Thomas FC et al (2009) Vorinostat inhibits brain metastatic colonization in a model of triple-negative breast cancer and induces DNA double-strand breaks. Clin Cancer Res 15:6148–6157 Google Scholar
Bertucci F, Finetti P, Cervera N et al (2006) Gene expression profiling shows medullary breast cancer is a subgroup of basal breast cancers. Cancer Res 66:4636–4644 ArticlePubMedCAS Google Scholar
Vincent-Salomon A, Gruel N, Lucchesi C et al (2007) Identification of typical medullary breast carcinoma as a genomic sub-group of basal-like carcinomas, a heterogeneous new molecular entity. Breast Cancer Res 9:R24 ArticlePubMed Google Scholar
Weigelt B, Horlings HM, Kreike B et al (2008) Refinement of breast cancer classification by molecular characterization of histological special types. J Pathol 216:141–150 ArticlePubMedCAS Google Scholar
Finetti P, Cervera N, Charafe-Jauffret E et al (2008) Sixteen-kinase gene expression identifies luminal breast cancers with poor prognosis. Cancer Res 68:767–776 ArticlePubMedCAS Google Scholar
Desmedt C, Piette F, Loi S et al (2007) Strong time dependence of the 76-gene prognostic signature for node-negative breast cancer patients in the TRANSBIG multicenter independent validation series. Clin Cancer Res 13:3207–3214 ArticlePubMedCAS Google Scholar
Ivshina AV, George J, Senko O et al (2006) Genetic reclassification of histologic grade delineates new clinical subtypes of breast cancer. Cancer Res 66:10292–10301 ArticlePubMedCAS Google Scholar
Hess KR, Anderson K, Symmans WF et al (2006) Pharmacogenomic predictor of sensitivity to preoperative chemotherapy with paclitaxel and fluorouracil, doxorubicin, and cyclophosphamide in breast cancer. J Clin Oncol 24:4236–4244 ArticlePubMedCAS Google Scholar
Hu Z, Fan C, Oh DS et al (2006) The molecular portraits of breast tumors are conserved across microarray platforms. BMC Genomics 7:96 ArticlePubMed Google Scholar
Perreard L, Fan C, Quackenbush JF et al (2006) Classification and risk stratification of invasive breast carcinomas using a real-time quantitative RT-PCR assay. Breast Cancer Res 8:R23 ArticlePubMed Google Scholar
Herschkowitz JI, Simin K, Weigman VJ et al (2007) Identification of conserved gene expression features between murine mammary carcinoma models and human breast tumors. Genome Biol 8:R76 ArticlePubMed Google Scholar
Hoadley KA, Weigman VJ, Fan C et al (2007) EGFR associated expression profiles vary with breast tumor subtype. BMC Genomics 8:258 ArticlePubMed Google Scholar
Mullins M, Perreard L, Quackenbush JF et al (2007) Agreement in breast cancer classification between microarray and quantitative reverse transcription PCR from fresh-frozen and formalin-fixed, paraffin-embedded tissues. Clin Chem 53:1273–1279 ArticlePubMedCAS Google Scholar
Oh DS, Troester MA, Usary J et al (2006) Estrogen-regulated genes predict survival in hormone receptor-positive breast cancers. J Clin Oncol 24:1656–1664 ArticlePubMedCAS Google Scholar
Parker JS, Mullins M, Cheang MC et al (2009) Supervised risk predictor of breast cancer based on intrinsic subtypes. J Clin Oncol 27:1160–1167 ArticlePubMed Google Scholar
Weigelt B, Hu Z, He X et al (2005) Molecular portraits and 70-gene prognosis signature are preserved throughout the metastatic process of breast cancer. Cancer Res 65:9155–9158 ArticlePubMedCAS Google Scholar
Irizarry RA, Hobbs B, Collin F et al (2003) Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 4:249–264 ArticlePubMed Google Scholar
Benito M, Parker J, Du Q et al (2004) Adjustment of systematic microarray data biases. Bioinformatics 20:105–114 ArticlePubMedCAS Google Scholar
Palmer C, Diehn M, Alizadeh AA, Brown POI (2006) Cell-type specific gene expression profiles of leukocytes in human peripheral blood. BMC Genomics 7:115 ArticlePubMed Google Scholar
Subramanian A, Tamayo P, Mootha VK et al (2005) Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA 102:15545–15550 ArticlePubMedCAS Google Scholar
Kim SYI (2009) Effects of sample size on robustness and prediction accuracy of a prognostic gene signature. BMC Bioinform 10:147 Article Google Scholar
Sotiriou C, Piccart MJI (2007) Taking gene-expression profiling to the clinic: when will molecular signatures become relevant to patient care? Nat Rev Cancer 7:545–553 ArticlePubMedCAS Google Scholar
Chang HY, Nuyten DS, Sneddon JB et al (2005) Robustness, scalability, and integration of a wound-response gene expression signature in predicting breast cancer survival. Proc Natl Acad Sci USA 102:3738–3743 ArticlePubMedCAS Google Scholar
Van Laere S, Beissbarth T, Van der Auwera I et al (2008) Relapse-free survival in breast cancer patients is associated with a gene expression signature characteristic for inflammatory breast cancer. Clin Cancer Res 14:7452–7460 ArticlePubMed Google Scholar
Hisada M, Kamiya S, Fujita K et al (2004) Potent antitumor activity of interleukin-27. Cancer Res 64:1152–1156 ArticlePubMedCAS Google Scholar
Pages F, Berger A, Camus M et al (2005) Effector memory T cells, early metastasis, and survival in colorectal cancer. N Engl J Med 353:2654–2666 ArticlePubMedCAS Google Scholar
Schmidt M, Bohm D, von Torne C et al (2008) The humoral immune system has a key prognostic impact in node-negative breast cancer. Cancer Res 68:5405–5413 ArticlePubMedCAS Google Scholar
de Kruijf EM, van Nes JG, Sajet A et al (2010) The predictive value of HLA class I tumor cell expression and presence of intratumoral Tregs for chemotherapy in patients with early breast cancer. Clin Cancer Res 16:1272–1280 ArticlePubMed Google Scholar
Denkert C, Loibl S, Noske A et al (2010) Tumor-associated lymphocytes as an independent predictor of response to neoadjuvant chemotherapy in breast cancer. J Clin Oncol 28:105–113 ArticlePubMedCAS Google Scholar
Yoon CH, Lee ES, Lim DS, Bae YSI (2009) PKR, a p53 target gene, plays a crucial role in the tumor-suppressor function of p53. Proc Natl Acad Sci USA 106:7852–7857 ArticlePubMedCAS Google Scholar
Liu H, Zang C, Fenner MH, Possinger K, Elstner EI (2003) PPARgamma ligands and ATRA inhibit the invasion of human breast cancer cells in vitro. Breast Cancer Res Treat 79:63–74 ArticlePubMedCAS Google Scholar
Jarrar MH, Baranova AI (2007) PPARgamma activation by thiazolidinediones (TZDs) may modulate breast carcinoma outcome: the importance of interplay with TGFbeta signalling. J Cell Mol Med 11:71–87 ArticlePubMedCAS Google Scholar
Yen WC, Prudente RY, Corpuz MR, Negro-Vilar A, Lamph WWI (2006) A selective retinoid X receptor agonist bexarotene (LGD1069, targretin) inhibits angiogenesis and metastasis in solid tumours. Br J Cancer 94:654–660 PubMedCAS Google Scholar
Chao WT, Kunz JI (2009) Focal adhesion disassembly requires clathrin-dependent endocytosis of integrins. FEBS Lett 583:1337–1343 ArticlePubMedCAS Google Scholar
Echarri A, Muriel O, Del Pozo MAI (2007) Intracellular trafficking of raft/caveolae domains: insights from integrin signaling. Semin Cell Dev Biol 18:627–637 ArticlePubMedCAS Google Scholar
Bakin AV, Safina A, Rinehart C et al (2004) A critical role of tropomyosins in TGF-beta regulation of the actin cytoskeleton and cell motility in epithelial cells. Mol Biol Cell 15:4682–4694 ArticlePubMedCAS Google Scholar
Untergasser G, Gander R, Lilg C et al (2005) Profiling molecular targets of TGF-beta1 in prostate fibroblast-to-myofibroblast transdifferentiation. Mech Ageing Dev 126:59–69 ArticlePubMedCAS Google Scholar
Groth S, Schulze M, Kalthoff H, Fandrich F, Ungefroren HI (2005) Adhesion and Rac1-dependent regulation of biglycan gene expression by transforming growth factor-beta. Evidence for oxidative signaling through NADPH oxidase. J Biol Chem 280:33190–33199 ArticlePubMedCAS Google Scholar